Home > Publications database > Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG). > print |
001 | 291665 | ||
005 | 20240717180809.0 | ||
024 | 7 | _ | |a 10.1002/hem3.123 |2 doi |
024 | 7 | _ | |a pmid:39011127 |2 pmid |
024 | 7 | _ | |a pmc:PMC11247273 |2 pmc |
037 | _ | _ | |a DKFZ-2024-01486 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Rücker, Frank G |0 0009-0003-1941-967X |b 0 |
245 | _ | _ | |a Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG). |
260 | _ | _ | |a [Philadelphia, Pennsylvania] |c 2024 |b Wolters Kluwer Health |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1721220910_2265 |2 PUB:(DE-HGF) |x Letter |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Corbacioglu, Andrea |b 1 |
700 | 1 | _ | |a Krzykalla, Julia |0 P:(DE-He78)5a7a75d1b29b770f98f1bb2062fc3df9 |b 2 |u dkfz |
700 | 1 | _ | |a Cocciardi, Sibylle |b 3 |
700 | 1 | _ | |a Lengerke, Claudia |b 4 |
700 | 1 | _ | |a Germing, Ulrich |b 5 |
700 | 1 | _ | |a Wulf, Gerald |b 6 |
700 | 1 | _ | |a Samra, Maisun A |b 7 |
700 | 1 | _ | |a Teichmann, Lino L |0 0000-0001-9489-7282 |b 8 |
700 | 1 | _ | |a Lübbert, Michael |b 9 |
700 | 1 | _ | |a Kühn, Michael W M |b 10 |
700 | 1 | _ | |a Bentz, Martin |b 11 |
700 | 1 | _ | |a Westermann, Jörg |b 12 |
700 | 1 | _ | |a Bullinger, Lars |b 13 |
700 | 1 | _ | |a Gaidzik, Verena I |b 14 |
700 | 1 | _ | |a Meid, Annika |b 15 |
700 | 1 | _ | |a Aicher, Sophia |b 16 |
700 | 1 | _ | |a Stegelmann, Frank |b 17 |
700 | 1 | _ | |a Weber, Daniela |b 18 |
700 | 1 | _ | |a Schrade, Anika |b 19 |
700 | 1 | _ | |a Thol, Felicitas |b 20 |
700 | 1 | _ | |a Heuser, Michael |b 21 |
700 | 1 | _ | |a Ganser, Arnold |b 22 |
700 | 1 | _ | |a Benner, Axel |0 P:(DE-He78)e15dfa1260625c69d6690a197392a994 |b 23 |u dkfz |
700 | 1 | _ | |a Döhner, Hartmut |b 24 |
700 | 1 | _ | |a Döhner, Konstanze |b 25 |
700 | 1 | _ | |a Group, German-Austrian Acute Myeloid Leukemia Study |b 26 |e Collaboration Author |
773 | _ | _ | |a 10.1002/hem3.123 |g Vol. 8, no. 7, p. e123 |0 PERI:(DE-600)2922183-3 |n 7 |p e123 |t HemaSphere |v 8 |y 2024 |x 2572-9241 |
909 | C | O | |o oai:inrepo02.dkfz.de:291665 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)5a7a75d1b29b770f98f1bb2062fc3df9 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 23 |6 P:(DE-He78)e15dfa1260625c69d6690a197392a994 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b HEMASPHERE : 2022 |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-06-14T08:57:17Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-06-14T08:57:17Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Double anonymous peer review |d 2023-06-14T08:57:17Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-27 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-27 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b HEMASPHERE : 2022 |d 2023-10-27 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-10-27 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-10-27 |
920 | 1 | _ | |0 I:(DE-He78)C060-20160331 |k C060 |l C060 Biostatistik |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C060-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|